VALIDOGEN GmbH
- CMO, CRO
PICHIA PASTORIS PROTEIN EXPRESSION EXCELLENCE:
VALIDOGEN is a leading contract research and development organization specializing in recombinant protein expression using its proprietary UNLOCK PICHIA® technology. With over 15 years of experience, VALIDOGEN offers a comprehensive suite of services, including protein expression feasibility studies, high-performance Pichia pastoris strain development and fermentation and protein purification development
The UNLOCK PICHIA® platform encompasses a unique and versatile toolbox of expression technologies - enabling both methanol-induced and methanol-free expression strategies - to meet the diverse requirements of clients across various industries, including biopharmaceuticals, food & feed, industrial biotechnology, and diagnostics.